海外の治験の状況「1」での検索結果
2039件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Prévention chez le receveur avec néphropathie à IgA primaire (NIGA) de la Récidive Après Transplantation rénale: ATG-F versus Basiliximab, comme traitements immunosuppresseurs d’induction. Etude PIRAT: A vs B - PIRAT
- IgA glomerulonephritis and first transplant MedDRA version: 12.1 Level: LLT Classification code 10018367 Term: Glomerulonephritis chronic MedDRA version: 12.1 Level: LLT Classification code 10023438 Term: Kidney transplant
- France, Spain
- 2010-04-09
Authorised
- Topical Amlodipine in Raynaud's Phenomenon
- The medical conditions under investigation in this trial are as follows: 1] Primary Raynaud's Phenomenon 2] Systemic Sclerosis (SSc) - otherwise known an Seconday Raynaud's Phenomenon. Raynaud's phenomenon is a disorder that affects the blood vessels in the fingers, toes, ears, and nose. This disorder is characterized by episodic attacks, called vasospastic attacks, that cause the blood vessels in the digits (fingers and toes) to constrict (narrow).
- United Kingdom
- 2010-03-18
Authorised
- International, multicenter, randomized, non-comparative controlled study of therapeutic intensification plus immunomodulation in HIV patients with long-term viral suppression - ERAMUNE-01
- HIV-1 Infection MedDRA version: 12.0 Level: LLT Classification code 10008919 Term: Chronic HIV infection
- France, Spain, United Kingdom
- 2009-11-20
Authorised
- The impact of heart rate on the effects of antihypertensive therapy on central and peripheral blood pressure
- Patients with dual chamber (atrium and ventricle) cardiac pacemaker placed due to sick sinus syndrome (at least 1 month after implantation) MedDRA version: 17.1 Level: HLT Classification code 10053103 Term: Heart rate and pulse investigations System Organ Class: 100000004848 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Estonia
- 2011-12-29
Authorised
- The effect of interferon beta-1a treatment on adaptability of the brain in patients with MS
- Multiple sclerosis MedDRA version: 14.0 Level: PT Classification code 10004504 Term: Beta interferon therapy System Organ Class: 10042613 - Surgical and medical procedures ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Netherlands
- 2011-11-07
Authorised
- Treatment of acute leukemia relapse after stem cell transplantation from healthy donors
- Allotransplanted patients with early acute leukemia repse (within 1 year after transplant);Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Norway
- 2011-08-22
Authorised
- Roll-over trial for continued TMC278 access
- HIV-1 infection MedDRA version: 14.1 Level: PT Classification code 10020161 Term: HIV infection System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Body processes [G] - Immune system processes [G12]
- Austria, Belgium, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom
- 2010-10-05
Authorised
- A novel long acting local anesthetic will be just in the treatment of Dupuytren’s contracture to give patients analgesia and anesthesia for at least 48 hours after single injection blocks of the median and ulnar nerves
- Introduction of collagenase clostridium histolyticum injection for the treatment of Dupuytren’s contractures. MedDRA version: 19.0 Level: PT Classification code 10013873 Term: Dupuytren's contracture operation System Organ Class: 10042613 - Surgical and medical procedures ;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Belgium
- 2016-05-13
Authorised
- A comparative study of platelet inhibition between the lower ticagrelor and prasugrel doses in patients with prior myocardial infarction
- In this study we aim to compare the platelet inhibition of 60mg ticagrelor bid versus 5mg prasugrel in patients with prior myocardial infarction within previous 1-3 years;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Greece
- 2017-06-14
Authorised
- A phase 3, open label, randomised, parallel group study to compare the effect on prevention and resolution of treatment related adverse events of a simplified, once daily regimen of a fixed dose combination tablet of emtricitabine and tenofovir DF versus twice daily co-formulated zidovudine and lamivudine (Combivir®) or zidovudine and lamivudine, in virologically suppressed, HIV infected patients taking efavirenz. - SWEET Study
- Human immunodeficiency virus (HIV-1) infection MedDRA version: 7.0 Level: PT Classification code 10020161
- Ireland, United Kingdom
- 2005-02-09
Authorised
- A 52-week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy when Administered to Patients with Type 2 Diabetes - GALLANT 4
- Men or women who are >18 years of age or older at the enrolment visit (visit 1) diagnosed with type 2 diabetes and treated with diet alone or on treatment with a single oral anti diabetic agent or low doses of two agents.
- Belgium, Hungary, Italy, Slovakia
- 2004-07-27
Authorised
- A phase I safety and tolerability study of infusing the autologous progeny of an adult CD34+ subset into patients with type I diabetes mellitus and a successful renal transplant. - Stem cell and diabetes study
- Diabetes mellitus type 1 and succesful renal transplant MedDRA version: 9.1 Level: LLT Classification code 10012638 Term: Diabetes with renal manifestations MedDRA version: 9.1 Level: LLT Classification code 10038533 Term: Renal transplant
- United Kingdom
- 2006-07-23
Authorised
- Pilot Study of the Intravesical Administration of EOquin Immediately Following Transurethral Resection in Patients with Superficial Bladder Cancer. - Not applicable
- Bladder Cancer Stage 1 without Cancer in Situ Patients will have transitional-cell carcinoma of the bladder, clinical TNM stage Ta or T1 and histologic grade G1 or G2 before transurethral resection. MedDRA version: 9 Level: PT Classification code 10005009
- Netherlands
- 2006-06-28
Authorised
- Interozeptive Aufmerksamkeit, Hitze-Schwelle und körperliche Symptome bei Patienten mit einer depressiven Episode, vor und nach Behandlung mit Duloxetin. Eine Pilotstudie mittels funktioneller Magnetresonanztomographie.
- Diagnose einer „Major Depression“ (DSM-IV: 296.xx). Der Gesamtscore der Hamilton-Depressionsskala-17 muß mindestens 15 betragen. Zudem müssen die Patienten unter Schmerzsymptomen leiden. Dieses Kriterium ist gemäß der klinischen Erfahrung erfüllt, wenn ein Minimum von 25mm auf einer visuellen Analogskala (0 bis 100mm) zur Messung der Intensität von Schmerzsymptomen erreicht wird. Das Item 13 der Hamilton-Depressionsskala-17 muß größer gleich 1 sein.
- Germany
- 2006-03-16
Authorised
- A study to evaluate if Lenalidomide works in patients with myelodysplastic syndrome and with a special genetic characteristic of the disease, and who need to receive blood transfusion
- Transfusion-dependant, low-or intermediate-1-risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, France, Germany, Israel, Italy, Spain, Sweden, United Kingdom
- 2005-02-23
Authorised
- A double-blind, double-dummy, randomized, parallel groups study to assess the Efficacy, Safety and Tolerability of switching patients with early Parkinson’s disease (PD) from Pramipexole IR to Pramipexole ER or Pramipexole IR.
- Male or female patients with idiopathic Parkinson's disease diagnosed within 5 years, with a modified Hoehn and Yahr scale of 1 to 3. MedDRA version: 9.1 Level: LLT Classification code 10061536 Term: Parkinson's disease
- France, Germany, Netherlands
- 2007-08-07
Authorised
- The effect of Pioglitazone on vascular and ventricular function in people with type 2 diabetes PICCOLA - PICCOLA
- Diabetes MedDRA version: 9.1 Level: LLT Classification code 10012601 Term: Diabetes mellitus MedDRA version: 9.1 Level: LLT Classification code 10012613 Term: Diabetes mellitus non-insulin-dependent MedDRA version: 9.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus
- United Kingdom
- 2007-05-30
Authorised
- Open Phase IV Clinical Study to Evaluate the Immunogenicity and Safety of a Rapid Immunization Schedule with FSME-IMMUN 0.25 ml JUNIOR in Healthy Children aged 3 - 15 Years
- Prevention of Tick-born encephalitis (TBE). The rapid immunization schedule recommended in the current SPC for FSME-IMMUN 0.5 ml (Day 0, Day 14) has been used in Austria for 20 years. FSME-IMMUN 0.25 ml was first administered in clinical trials in the year 2001 and the rapid immunization schedule is recommended for children ranging 1 to 16 years of age. However, limited data on immunogenicity when using the rapid immunization schedule in children exist. MedDRA version: 9.1 Level: LLT Classification code 10043847 Term: Tick-borne viral encephalitis
- Czech Republic
- 2007-03-27
Authorised
- Prospective, randomized, open, 2-arm national multi-center study to evaluate the value of Rituximab in humoral chronic rejection after renal transplantation - Rituximab 2006
- Renal transplant patients beyond 1 year post Tx, suffering from CAN and histologically proven C4d deposits and/or plasma cell and/or B-Lymphocyte (CD20+ cells) infiltration of their grafts
- Germany
- 2007-03-26
Authorised
- Vergleich einer strukturierten störungsspezifischen Gruppenpsychotherapie plus Placebo oder Methylphenidat versus einer psychiatrischen Beratung plus Placebo oder Methylphenidat bei ADHS im Erwachsenenalter – eine erste randomisierte Multizenter-Studie - Wirksamkeit von Psychotherapie bei ADHS im Erwachsenenalter
- Aufmerksamkeitsdefizit/Hyperaktitivitätsstörung (ADHS) im Erwachsenenalter (F90.0). ADHS ist eine relevante psychiatrische Erkankung mit häufig in das Erwachsenenalter persisitierender Aufmerksamkeits- und Konzentrationsstörung, Hyperaktivität, Impulsivität, emotionaler Instabilität und Desorgansiertheit. Die Prävalenz liegt bei ca. 1-4 % im Erwachsenenalter. Siehe Prüfplan Kapitel 3. MedDRA version: 8.1 Level: LLT Classification code 10003736 Term: Attention deficit/hyperactivity disorder
- Germany
- 2006-09-22
